ADAR1 Capital Management reports Tenax Therapeutics common share purchase worth $1.38 million

Reuters2026/09/02 21:53

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

ADAR1 Capital Management, a 10% owner, increased its stake in Tenax Therapeutics to 5,624,151 shares.
The position rose through purchases totaling 770,333 shares at weighted-average prices near USD 1.79 per share.
Holdings are reported as indirect ownership through private investment funds managed by ADAR1 Capital Management.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000019), on September 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

ADAR1 Capital Management reports Tenax Therapeutics common share purchase worth $1.38 million

You may also like

Crypto prices